Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1989 • 2,245 citations

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 • 2,115 citations

The Sentinel Node in Breast Cancer — A Multicenter Validation Study

1998 • 2,025 citations

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

1997 • 1,783 citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

1999 • 1,315 citations

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1983 • 1,028 citations

Management and survival of female breast cancer: Results of a national survey by the American college of surgeons

1980 • 657 citations

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

1998 • 581 citations

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1978 • 465 citations

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

1994 • 435 citations

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up

1999 • 433 citations

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.

1995 • 422 citations

Incidence and Impact of Documented Eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated With Neoadjuvant Chemotherapy

1999 • 351 citations

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

1995 • 348 citations

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1994 • 208 citations

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi

1996 • 196 citations

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.

1995 • 186 citations

The Prognostic Significance of Lymph Node Metastases After Preoperative Chemotherapy for Locally Advanced Breast Cancer

1989 • 175 citations

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1995 • 158 citations

Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy

1989 • 156 citations

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

1997 • 156 citations

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer

1998 • 156 citations

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

1998 • 142 citations

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.

1998 • 117 citations

Prediction of response to primary chemotherapy for operable breast cancer

1999 • 111 citations

Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy

1997 • 74 citations

Treatment of curable carcinoma of the breast

1977 • 67 citations

Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.

1995 • 55 citations

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1989 • 52 citations

Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies.

1998 • 50 citations

Locally advanced non-metastatic breast cancer: Analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach

1995 • 43 citations

The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.

1999 • 36 citations

The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma.

1996 • 32 citations

Prognostic Value of the S‐Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy

1993 • 30 citations

Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer.

1998 • 11 citations

Primary chemotherapy in breast cancer: Significantly enhanced clinical and pathological response with docetaxel

1999 • 5 citations

Deleted Work

1955 • 0 citations